Cargando…

Proton dynamics in cancer

Cancer remains a leading cause of death in the world today. Despite decades of research to identify novel therapeutic approaches, durable regressions of metastatic disease are still scanty and survival benefits often negligible. While the current strategy is mostly converging on target-therapies aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Veronica, De Milito, Angelo, Harguindey, Salvador, Reshkin, Stephan J, Wahl, Miriam L, Rauch, Cyril, Chiesi, Antonio, Pouysségur, Jacques, Gatenby, Robert A, Rivoltini, Licia, Fais, Stefano
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905351/ https://www.ncbi.nlm.nih.gov/pubmed/20550689 http://dx.doi.org/10.1186/1479-5876-8-57

Ejemplares similares

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013)

Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs – an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research
por: Harguindey, Salvador, et al.
Publicado: (2013)

Proton pump inhibitors for the treatment of cancer in companion animals
por: Walsh, Megan, et al.
Publicado: (2015)

More insights into the immunosuppressive potential of tumor exosomes
por: Huber, Veronica, et al.
Publicado: (2008)

The Prime and Integral Cause of Cancer in the Post-Warburg Era
por: Harguindey, Salvador, et al.
Publicado: (2023)

Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis
por: Harguindey, Salvador, et al.
Publicado: (2022)

Evidence-based support for the use of proton pump inhibitors in cancer therapy
por: Fais, Stefano
Publicado: (2015)

Hydrogen ion dynamics and the Na(+)/H(+) exchanger in cancer angiogenesis and antiangiogenesis
por: Orive, G, et al.
Publicado: (2003)

Curing cancer? Further along the new pH-centric road and paradigm
por: Harguindey, S., et al.
Publicado: (2018)

A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
por: Harguindey, Salvador, et al.
Publicado: (2020)

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
por: Logozzi, Mariantonia, et al.
Publicado: (2009)

Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H(+)-Centered Anticancer Paradigm of the Late Post-Warburg Era
por: Harguindey, Salvador, et al.
Publicado: (2020)

Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
por: Marino, M L, et al.
Publicado: (2010)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question
por: Alfarouk, Khalid O., et al.
Publicado: (2014)

Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question
por: Alfarouk, Khalid O., et al.
Publicado: (2014)

The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
por: Alfarouk, Khalid O., et al.
Publicado: (2019)

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
por: Alfarouk, Khalid O, et al.
Publicado: (2015)

The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
por: Alfarouk, Khalid O., et al.
Publicado: (2020)

Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
por: Fais, Stefano, et al.
Publicado: (2014)

Erratum to: Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
por: Fais, Stefano, et al.
Publicado: (2014)

MIAQuant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices
por: Casiraghi, Elena, et al.
Publicado: (2017)

Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles
por: Andreola, Giovanna, et al.
Publicado: (2002)

The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
por: Alfarouk, Khalid O., et al.
Publicado: (2020)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients
por: Rodolfo, Monica, et al.
Publicado: (2022)

Transmissible cancers, are they more common than thought?
por: Ujvari, Beata, et al.
Publicado: (2016)

Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies
por: Harguindey, Salvador, et al.
Publicado: (2019)

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
por: Daveri, Elena, et al.
Publicado: (2020)

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections
por: Casiraghi, Elena, et al.
Publicado: (2018)

Immune response markers in sentinel nodes may predict melanoma progression
por: Rodolfo, Monica, et al.
Publicado: (2014)

The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela
por: Cardone, Rosa Angela, et al.
Publicado: (2019)

Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy
por: Spugnini, Enrico P, et al.
Publicado: (2010)

Proton Therapy in LMICs: Is the Need Justified?
por: Chilukuri, Srinivas, et al.
Publicado: (2022)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Unconventional transport of metal ions and protons by Nramps
por: Rudnick, Gary
Publicado: (2019)

Recognizing the complexity of soil organic carbon dynamics in vegetated coastal habitats
por: Glatzel, Stephan, et al.
Publicado: (2020)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
por: Aronson, Jeffrey K.
Publicado: (2016)

Otopetrin-1: A sour-tasting proton channel
por: Ramsey, I. Scott, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vsim5uvqdujasq7j8ht3oj8v09